ArticleComputational and structural biotechnology journal2026
From Biomedical Datasets to Fairness-Aware Recommendations: An Integrated Data Orchestration Pipeline for Binary Clinical Predictions.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many problems in biomedicine can be posed as binary classification. When they are addressed using artificial intelligence methods, though, average performance alone does not show whether a dataset is artificial intelligence ready, whether the endpoint is clinically valid, or whether errors are unevenly distributed across patient subgroups. This article presents the Fairness-Aware Data Orchestration Pipeline (FADOP), a reusable workflow that analyzes biomedical datasets, trains baseline binary classifiers, audits subgroup error patterns, tests mitigation strategies, and generates a documented recommendation. Such a pipeline is intended for systematic evaluation before clinical translation, not as an automatic deployment tool. Two publicly available case studies illustrate its use: the HIV-related ACTG175 dataset was repurposed from a treatment-comparison trial into a 1-year baseline mortality-prediction task, with death by day 365 as the positive class rather than the cid AIDS/failure composite endpoint; then, a stroke-risk dataset was analyzed as direct event prediction. The case studies show how the same workflow can generate cohort, performance, fairness, mitigation, and recommendation evidence across different rare-event clinical datasets.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.